Scientists have incorporated nanotechnology, material science, and the clinical imaging modality MRI, to create a nanosized probe capable of noninvasively visualizing and quantifying the blood vessel growth in tumors in a preclinical model. Studies in cell and preclinical animal models showed increase uptake of vascular targeted-nanoprobes over non-targeted nanoprobes.